Fig 2. Survival rate in the 23 SFTS patients who received favipiravir.
Overall survival rate in the 23 SFTS patients who received favipiravir is shown based on the survival time plotted using the Kaplan-Meier method (A). Survival probabilities of patients with higher SFTSV viremia level (≥ 1 × 105 copies/mL, dotted line, n = 10) and that of patients with lower SFTSV viremia level (< 1 × 105 copies/mL, solid line, n = 13) are shown (B).